Боль при болезни Паркинсона
Аннотация
Болезнь Паркинсона - широко распространенное нейродегенеративное заболевание, характеризующееся двигательными симптомами и рядом немоторных проявлений, среди которых одним из наиболее частых и дезадаптирующих является боль. Боль испытывают около 40-80 % пациентов с болезнью Паркинсона, что превышает частоту в общей популяции. Болевой синдром оказывает большое негативное влияние на общее состояние пациента, его качество жизни и требует отдельного подхода к диагностике и терапии. В статье описываются этиологические и патогенетические аспекты боли при болезни Паркинсона, ее классификация и принципы терапии.
Об авторе
А. А. Пилипович
ФГАОУ ВО «Первый Московский государственный медицинский университет имени И. М. Сеченова (Сеченовский университет)» Минздрава России
Россия
Россия
Список литературы
1. Buzas B., Max M. B. Pain in Parkinson disease. Neuroljgy. 2004; 62: 2156-2157.
2. Lee M. A., Walker R. W., Hildreth T. G., et al. A survey of pain in idiopathic Parkinson’s disease. J. Pain Symptom Manage. 2006; 32: 462-469.
3. Махнеев С. О., Левин О. С. Хронические болевые синдромы при болезни Паркинсона. Журн.неврол.и психиатрии им. С. С. Корсакова. 2013; 8.2.
4. Giuffrida R, Vingerhoets FJ, Bogousslavsky J, Ghika J. Pain in Parkinson’s disease. Rev Neurol (Paris) 2005; 161:407-418.
5. O’Sullivan SS, Williams DR, Gallagher DA, Massey LA, Silveira-Moriyama L, Lees AJ. Nonmotor symptoms as presenting complaints in Parkinson ’s disease: a clinicopathologicalstudy. Mov Disord 2008; 23: 101-106.
6. Wasner G, Deuschl G. Pains in Parkinson disease - many syndromes under one umbrella. Nat Rev Neurol. 2012; 5: 284-294.
7. Lin CH, Wu RM, Chang HY, Chiang YT, Lin HH. Preceding pain symptoms and Parkinson’s disease: a nationwide populationbased cohort study. Eur J Neurol 2013; 20: 1398-1404.
8. Letro G. H., Quagliato E. M. A.B., Viana M. A. Pain in Parkinson's Disease. 2009; 67: 585-590.
9. Brefel-Courbon C, Payoux P, Thalamas C, et al. Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study. Mov Disord. 2005; 12: 1557-1563.
10. Young Blood MR, Ferro MM, Munhoz RP et al. Classification and Characteristics of Pain Associated with Parkinson's Disease. Parkinsons Dis. 2016; 6067132. Epub 2016 Oct 5.
11. Juri C, Rodriguez-Oroz M, Obeso JA. The pathophysiological basis of sensory disturbances in Parkinson's disease. J Neurol Sci. 2010; 289 (1-2): 60-65.
12. Mylius V, Engau I, Teepker M, et al. Pain sensitivity and descending inhibition of pain in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2009; 1: 24-28.
13. Conte A, Khan N, Defazio G, et al. Pathophysiology of somatosensory abnormalities in Parkinson disease. Nat Rev Neurol. 2013 Dec; 9 (12): 687-697.
14. Scherder E, Wolters E, Polman C, et al. Pain in Parkinson's disease and multiple sclerosis: its relation to the medial and lateral pain systems. Neurosci Biobehav Rev. 2005; 7: 1047-56.
15. Nolano M, Provitera V, Estraneo A, et al. Sensory deficit in Parkinsons disease: evidence of a cutaneous denervation. Brain. 2008; 131 (Pt 7): 1903-1911.
16. Бобков А. В. Особенности болевого синдрома и полиневропатии при болезни Паркинсона. Автореферат на соискание уч.степ.кмн. 2014, Санкт-Петербург, 24 с.
17. Schestatsky P, Kumru H, Valls-Solé J, et al. Neurophysiologic study of central pain in patients with Parkinson disease. Neurology. 2007; 23: 2162-2169.
18. Tison F, Wenning GK, Volonte MA, Poewe WR, Henry P, Quinn NP. Pain in multiple system atrophy. J Neurol. 1996; 2: 153-156.
19. Nègre-Pagès L, Regragui W, Bouhassira D, et al. Chronic pain in Parkinson's disease: the cross-sectional French DoPaMiP survey.Mov Disord. 2008; 10: 1361-1369.
20. Lee MA, Walker RW, Hildreth TJ, Prentice WM. A survey of pain in idiopathic Parkinson's disease. J Pain Symptom Manage. 2006; 5:462-469.
21. Defazio G, Berardelli A, Fabbrini G, et al. Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study.Arch Neurol. 2008; 9: 1191-1194.
22. Beiske AG, Loge JH, Ronningen A, Svensson E. Pain in Parkinson's disease: Prevalence and characteristics. Pain. 2009; 141 (1-2): 173-177.
23. Lin XJ, Yu N, Lin XG, et al. A clinical survey of pain in Parkinson's disease in Eastern China. !nt Psychogeriatr. 2016; 2: 283-289.
24. Burke AL, Mathias JL, Denson LA. Psychological functioning of people living with chronic pain: a meta-analytic review. Br J Clin Psychol. 2015; 3: 345-360.
25. Fil A, Cano-de-la-Cuerda R, Munoz-Hellin E, et al. Pain in Parkinson disease: a review of the literature. Parkinsonism Relat Disord. 2013; 3:285-294.
26. Defazio G, Gigante A, Mancino P, Tinazzi M. The epidemiology of pain in Parkinson's disease. J Neural Transm (Vienna). 2013; 4: 583-586.
27. Zhang LM, Chen YQ, Li WJ, et al. Association between mutations of SCN9A gene and pain related to Parkinsonism.2013; 1: 17-20.
28. Greenbaum L, Tegeder 1, Barhum Y, et al. Contribution of genetic variants to pain susceptibility in Parkinson disease. Eur J Pain. 2012; 9: 1243-1250.
29. Ming-Tsung Tseng, Chin-Hsien Lin. Pain in early-stage Parkinson’s disease: Implications from clinical features to pathophysiology mechanisms. Journal of the Formosan Medical Association (2017) 116,571-581.
30. Пилипович А. Депрессия при болезни Паркинсона. Врач 2012; 9: 60-65.
31. de Sales Coriolano M. D. G.W., de Siqueira Balbino J. M., da Silva B. R.V., et al. Pain characterization in patients with Parkinson's disease. Revista Dor. 2014; 2: 78-82.
32. Mylius V., Ciampi de Andrade D., Gisbert Cury R., et al. Pain in Parkinson’s Disease: Current Concepts and a New Diagnostic Algorithm. Mov Disord. 2015; 2 (Issue 4): 357-364.
33. Ford B. Pain in Parkinson's disease. Clin Neurosci. 1998; 2: 63-72.
34. Skogar O, Lokk J. Pain management in patients with Parkinson's disease: challenges and solutions. J Multidiscip Healthc. 2016; 9:469-479.
35. Ford B. Pain in Parkinson's disease. Mov Disord. 2010; 25 Suppl 1:98-103.
36. Aquino CC, Fox SH. Clinical spectrum of levodopa-induced complications. Mov Disord. 2015; 1: 80-89.
37. Cury RG, Galhardoni R, Fonoff ET, et al. Effects of deep brain stimulation on pain and other nonmotor symptoms in Parkinson disease. Neurology. 2014; 16: 1403-1409.
38. Дамулин И. В. Использование Ипидакрина в неврологической практике. Трудный пациент. 2007; 11: 15-19.
39. Дамулин И. В., Живолупов С. А., Зайцев О. С. с соавт. Нейромидин в клинической практике. М: «МИА», 2016: 60 стр.
40. Javoy-Agid F, Agid Y. 1s the mesocorticaldopaminergic system involved in Parkinson disease? Neurology. 1980; 12: 1326-1330.
41. Rana AQ, Siddiqui 1, Mosabbir A, et al. Association of pain, Parkinson's disease, and restless legs syndrome. J Neurol Sci. 2013; 327 (1-2): 32-34.
42. Ford B, Louis ED, Greene P, Fahn S. Oral and genital pain syndromes in Parkinson's disease. Mov Disord. 1996; 4: 421-426.
43. Factor SA, Weiner WJ, editors. Parkinson's Disease: Diagnosis and Clinical Management. New York: Demos Medical Publishing; 2002.
44. Jancovic J, Nour F. Respiratory dyskinesias in Parkinson's disease. Neurology 1986; 36: 303-304.
45. Halliday G. H., Barker R. A., Rowe D. B. Non-dopamine lesions in Parkinson’s disease. Oxford University Press 2011, 314 P.
46. Cattaneo C., Kulisevsky J., Tubazio V., Castellani P. Long-term Efficacy of Safinamide on Parkinson’s Disease Chronic Pain. Adv Ther. 2018; 35: 515-522
47. Cattaneo C, Barone P, Bonizzoni E, Sardina M. Effects of safinamide on pain in fluctuating Parkinson’s disease patients: a post hoc analysis. J Parkinsons Dis. 2017; 7 (1): 95-101.
48. Salvati P, Maj R, Caccia C, Cervini MA, Fornaretto MG, et al. Biochemical and electrophysiological studies on the mechanism of action of PNU-151774E, a novel antiepileptic compound. J Pharmacol Exp Ther. 1999; 288: 1151-1159.
49. Miladinovic T, Nashed MG, Sungh G. Overview of glutamatergic dysregulation in central pathologies. Biomolecules. 2015; 5:3122-3141.
50. Bleakman D, Alt A, Nisenbaum ES. Glutamate receptors and pain. Semin Cell Dev Biol.2006; 17 (5): 592-604.
51. Fayyaz M, Jaffery S S, Anwer F, Zil. E. Ali A., Anjum 1. The Effect of Physical Activity in Parkinson’s Disease: A Mini-Review. Cureus 10 (7): e2995.
52. Allen NE, Moloney N, van Vliet V, Canning CG. The rationale for exercise in the management of pain in Parkinson’s disease. J Parkinsons Dis. 2015, 5: 229-239.
Рецензия
Для цитирования:
Пилипович А.А. Боль при болезни Паркинсона. Медицинский алфавит. 2018;4(33):34-39.
For citation:
Pilipovich A.A. Pain in Parkinson 's disease. Medical alphabet. 2018;4(33):34-39. (In Russ.)
Просмотров:
1164
Послать статью по эл. почте 